Give it a break doc. Your nit picking is bordering on desperation. I am pretty happy with reducing deaths, heart attacks and strokes, and I'm guessing those HF patients feel the same. No, they didn't report on re-evaluating for all the criteria to determine classification, but with the reduction in heart attack, stroke, and death, I think we're on the right track.
Cell Therapy News/Articles, page-13662
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.44 | $2.568M | 1.750M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 69388 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 15927 | 9 |
View Market Depth
| Last trade - 13.16pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |